abrdn Life Sciences Investors Other Assets

As of the most recent data (March 2026), HQL shows a other assets of $0. That compares with $410M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HQL's other assets is now $0 (was $410M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether abrdn Life Sciences Investors is outperforming or lagging.

Tracking HQL's other assets over time shows whether abrdn Life Sciences Investors is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $410M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other assets page, Stockcircle has abrdn Life Sciences Investors's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other assets (currently $0) with ownership activity and broader fundamentals.